Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Organic Revenue Growth YoY (%) (%)
Medtronic Form 8-K World-Wide Revenue Tables (Published Organic Growth)
Latest, FY2023
-4.8%
Period ended Apr 30, 2023
Change on a year earlier
+1.4 pts
-6.2% in FY2022
History
6 years
Since FY2018
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Organic Revenue Growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Apr 30, 2023 | -4.8% | +1.4 pts | Medtronic SEC 8K_EARNINGS — FY2023Q4 (filed 2023-05-25) ↗ |
| FY2022 | Apr 30, 2022 | -6.2% | -21.6 pts | Medtronic SEC 8K_EARNINGS — FY2022Q4 (filed 2022-05-26) ↗ |
| FY2021 | Apr 30, 2021 | 15.4% | +9.9 pts | Medtronic SEC 8K_EARNINGS — FY2021Q4 (filed 2021-05-27) ↗ |
| FY2020 | Apr 30, 2020 | 5.5% | -33.5 pts | Medtronic SEC 8K_EARNINGS — FY2020Q4 (filed 2020-05-21) ↗ |
| FY2019 | Apr 30, 2019 | 39.0% | +38.0 pts | Medtronic SEC 8K_EARNINGS — FY2019Q4 (filed 2019-05-23) ↗ |
| FY2018 | Apr 30, 2018 | 1.0% | – | Medtronic SEC 8K_EARNINGS — FY2018Q4 (filed 2018-05-24) ↗ |
Cite this data
StockData. (2026). Medtronic Respiratory, Gastrointestinal & Renal (Legacy through FY2023Q4) — Organic Revenue Growth YoY (%) (%), annual FY2018–FY2023 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/ms-rgr-leg-ww-org
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.